To select candidate genes in blood cancer cells associated with EGFR signaling pathway drugs, data on 167 blood cancer cell lines from GDSC1 and six EGFR signaling pathway drugs were analyzed. The gene discussed is EGFR; the disease is hematopoietic and lymphoid system neoplasm.